No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Carr's Group announced a strategic manufacturing partnership with French animal health company Vtalis on Friday, to develop an enhanced range of Tracesure boluses, with distribution due to begin in autumn 2025.
The London-listed firm said the move followed its decision to close its ANIMAX production facility in June, allowing it to shift resources towards innovation and growth in livestock nutrition.
It said the partnership was expected to deliver operational savings while maintaining Tracesure's leading position in the UK and Irish markets.
Vtalis, a specialist in precision bolus supplementation, would support Carr's in developing new science-backed formulations aimed at improving animal health and supporting sustainable farming practices.
Carr's said the collaboration would support its strategy of boosting on-farm productivity and addressing global food security challenges.
The combination of Vtalis' manufacturing expertise and Carr's nutrition capabilities was intended to drive innovation, improve efficiency, and enhance product delivery.
"This is a key strategic milestone as we reposition the Group as a focused, pure-play agriculture business," said chief executive officer Joshua Hoopes
"Partnering with Vtalis enables us to build a more efficient platform for sustainable growth, while strengthening our customer offering and creating long-term value for shareholders."
At 1307 BST, shares in Citywire were up 5.53% at 146.18p.
Reporting by Josh White for Sharecast.com.
The value of investments can go down in value as well as up, so you could get back less than you invest. It is therefore important that you understand the risks and commitments. This website is not personal advice based on your circumstances. So you can make informed decisions for yourself we aim to provide you with the best information, best service and best prices. If you are unsure about the suitability of an investment please contact us for advice.